Most cancer centers do not disclose payer-specific prices

Most most cancers facilities don’t disclose payer-specific costs

Most cancer centers do not disclose payer-specific prices

Most U.S. Nationwide Most cancers Institute-designated most cancers facilities don’t present required value transparency, however markup on parenteral chemotherapy seems widespread, in line with a examine revealed on-line April 18 in JAMA Inner Drugs.

Roy Xiao, M.D., from Massachusetts Eye and Ear in Boston, and colleagues assessed the extent of value markup by hospitals on parenterally administered most cancers therapies and value variation amongst hospitals. The evaluation included non-public payer-specific negotiated costs for the highest 25 parenteral (e.g., injectable or infusible) most cancers therapies by Medicare Half B spending in 2019 utilizing publicly out there hospital value transparency information.

The researchers discovered that 27 of 61 Nationwide Most cancers Institute-designated most cancers facilities disclosed non-public payer-specific costs for at the least one top-selling most cancers remedy as required by federal laws. Throughout all facilities and payers, median drug value markups ranged from 118.4 p.c (sipuleucel-T) to 633.6 p.c (leuprolide). Value ratios ranged from 2.2 (pertuzumab) to fifteen.8 (leuprolide) throughout facilities. Throughout the identical heart, negotiated costs additionally assorted significantly between payers, with median within-center value ratios for most cancers therapies starting from 1.8 (brentuximab) to 2.5 (bevacizumab).

“The findings of this cross-sectional examine counsel that, to scale back the monetary burden of most cancers therapy for sufferers, establishment of public insurance policies to discourage or stop extreme hospital value markups on parenteral chemotherapeutics could be helpful,” the authors write.

A number of authors disclosed monetary ties to the medical and medical health insurance industries.



Copyright © 2022 HealthDay. All rights reserved.

Quotation:
Most most cancers facilities don’t disclose payer-specific costs (2022, April 18)
retrieved 18 April 2022
from https://medicalxpress.com/information/2022-04-cancer-centers-disclose-payer-specific-prices.html

This doc is topic to copyright. Other than any honest dealing for the aim of personal examine or analysis, no
half could also be reproduced with out the written permission. The content material is supplied for info functions solely.

Learn Extra

Leave a Comment

Your email address will not be published.